TSX News -
CN to Report Second-Quarter 2024 Financial and Operating Results on July 23, 2024
MONTREAL, July 08, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its second-quarter 2024 financial and operating […]
TSX News -
American Hotel Income Properties REIT LP to Host Second Quarter 2024 Results Conference Call on August 7, 2024
VANCOUVER, British Columbia, July 08, 2024 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”, “the Company”) (TSX: HOT.UN, […]
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
Extensive Issued and Pending IP Patent Applications Acquired with License Agreement SARASOTA, FL, July 08, 2024 (GLOBE NEWSWIRE) — Silo […]
SELLAS Receives European Medicines Agency Orphan Drug Designation for SLS009 for the Treatment of Acute Myeloid Leukemia
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a […]
Treasure Global Inc Acquires an Innovative Sports Engagement & Gaming Platform
NEW YORK and KUALA LUMPUR, Malaysia, July 08, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“Treasure Global” or […]
Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular […]
Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) in the EU for the treatment […]
SRIVARU (SVMH) Deploys Advanced AI Platform to Manage Lead Generation Platform for PRANA 2.0 Electric Motorcycle
GRAND CAYMAN, Cayman Islands and COIMBATORE, India, July 08, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW) (“SRIVARU” […]
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
According to the agreement, SciSparc’s pharmaceuticals assets are valued at approximately $11.6 million TEL AVIV, Israel, July 08, 2024 (GLOBE […]
HeartCore Partners with Hitachi Systems, Ltd. to Offer Combined Package of HeartCore CMS and GRED Web Security Assessment Cloud
NEW YORK and TOKYO, July 08, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
